IDEXX Laboratories (IDXX) director amends Form 3 to add 1 share
Filing Impact
Filing Sentiment
Form Type
3/A
Rhea-AI Filing Summary
IDEXX Laboratories director Karen Peacock filed an amended initial insider report to correct her stated holdings. The Form 3/A clarifies that she beneficially owns 1 share of common stock directly, which was inadvertently omitted from her original Form 3. The amendment does not reflect a new buy or sell transaction; it simply updates the ownership record.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Peacock Karen
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What does the IDEXX (IDXX) Form 3/A filed by Karen Peacock report?
The Form 3/A reports a correction to Karen Peacock’s initial insider holdings. It clarifies that she directly owns 1 share of IDEXX common stock that was inadvertently omitted from her original Form 3, without indicating any new purchase or sale.
Why was an amended Form 3/A needed for IDEXX (IDXX) director Karen Peacock?
The amended Form 3/A was needed because one share of IDEXX common stock was inadvertently omitted from Karen Peacock’s original Form 3. The amendment corrects the record so that her reported direct ownership accurately includes this 1 share.
Does the IDEXX (IDXX) Form 3/A indicate any change in Karen Peacock’s insider status?
The Form 3/A does not indicate a change in Karen Peacock’s insider status. She remains a director, and the amendment solely updates her reported holdings to include 1 directly owned share that was mistakenly left out previously.